If you want to pick your own biotech stocks, rather than investing in a biotech-focused ETF or mutual fund, the author of today’s article advises… Read More »Biotech Bargains: 4 Names Trading Far Below Their Average Price Targets
“We’re not in a true bull market – not by a long shot – but the recent bear has pushed prices down and the current… Read More »The Right Stocks Right Now: 3 Penny Stocks With “Strong Buy” Ratings And “Massive Upside Potential”
When it comes to pricing shares for an initial public offering, the author of today’s article notes that they need to be priced “high enough… Read More »Hitching A Ride On The “Failed” Lyft IPO